236 related articles for article (PubMed ID: 36926315)
1. Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship.
Selvakumar S; Liu A; Chaturvedi S
Front Med (Lausanne); 2023; 10():1137019. PubMed ID: 36926315
[TBL] [Abstract][Full Text] [Related]
2. Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura.
Brown J; Potugari B; Mazepa MA; Kohli R; Moliterno AR; Brodsky RA; Vaught JA; Burwick R; Chaturvedi S
Ann Hematol; 2022 Oct; 101(10):2159-2167. PubMed ID: 35932324
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura.
Bae SH; Kim SH; Bang SM
Blood Res; 2022 Apr; 57(S1):37-43. PubMed ID: 35483924
[TBL] [Abstract][Full Text] [Related]
4. Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura.
Brodsky MA; Sukumar S; Selvakumar S; Yanek L; Hussain S; Mazepa MA; Braunstein EM; Moliterno AR; Kickler TS; Brodsky RA; Cataland SR; Chaturvedi S
Am J Hematol; 2021 Dec; 96(12):1587-1594. PubMed ID: 34460124
[TBL] [Abstract][Full Text] [Related]
5. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura.
Pavenski K; Huang SS; Patriquin CJ
Expert Rev Hematol; 2021 Nov; 14(11):1027-1040. PubMed ID: 34747320
[TBL] [Abstract][Full Text] [Related]
6. Survival after acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP) - cognitive functioning and health-related quality of life impact: a descriptive cross-sectional survey of adults living with iTTP in the United Kingdom.
Holmes S; Podger L; Bottomley C; Rzepa E; Bailey KMA; Chandler F
Hematology; 2021 Dec; 26(1):465-472. PubMed ID: 34238132
[TBL] [Abstract][Full Text] [Related]
7. How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge.
Akwaa F; Antun A; Cataland SR
Blood; 2022 Aug; 140(5):438-444. PubMed ID: 35667044
[TBL] [Abstract][Full Text] [Related]
8. The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review.
Joseph A; Joly BS; Picod A; Veyradier A; Coppo P
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176509
[TBL] [Abstract][Full Text] [Related]
9. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
Yue C; Su J; Fan X; Song L; Jiang W; Xia J; Shi T; Zhang X; Li X
Orphanet J Rare Dis; 2020 Aug; 15(1):225. PubMed ID: 32859237
[TBL] [Abstract][Full Text] [Related]
11. Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies.
Mazepa MA; Park YA; Raval JS
Transfus Med Rev; 2019 Oct; 33(4):248-255. PubMed ID: 31645275
[TBL] [Abstract][Full Text] [Related]
12. Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes.
Kucukyurt S; Eskazan AE
J Blood Med; 2020; 11():319-326. PubMed ID: 33061729
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States.
Adeyemi A; Razakariasa F; Chiorean A; de Passos Sousa R
Res Pract Thromb Haemost; 2022 Aug; 6(6):e12802. PubMed ID: 36176310
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission.
Sukumar S; Brodsky M; Hussain S; Yanek L; Moliterno A; Brodsky R; Cataland SR; Chaturvedi S
Blood Adv; 2022 Feb; 6(4):1264-1270. PubMed ID: 34461629
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age.
Rottenstreich A; Dor S; Keren-Politansky A; Sarig G; Nadir Y; Ellis M; Spectre G; Kirgner I; Pikovsky O; Arad A; Dann EJ; Kalish Y
J Thromb Thrombolysis; 2021 Jan; 51(1):187-193. PubMed ID: 32388825
[TBL] [Abstract][Full Text] [Related]
16. [Endothelial dysfunction in thrombotic thrombocytopenic purpura: therapeutic perspectives].
Prevel R; Roubaud-Baudron C; Tellier E; Le Besnerais M; Kaplanski G; Veyradier A; Benhamou Y; Coppo P;
Rev Med Interne; 2021 Mar; 42(3):202-209. PubMed ID: 33455838
[TBL] [Abstract][Full Text] [Related]
17. The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians.
Mancini I; Giacomini E; Pontiggia S; Artoni A; Ferrari B; Pappalardo E; Gualtierotti R; Trisolini SM; Capria S; Facchini L; Codeluppi K; Rinaldi E; Pastore D; Campus S; Caria C; Caddori A; Nicolosi D; Giuffrida G; Agostini V; Roncarati U; Mannarella C; Fragasso A; Podda GM; Birocchi S; Cerbone AM; Tufano A; Menna G; Pizzuti M; Ronchi M; De Fanti A; Amarri S; Defina M; Bocchia M; Cerù S; Gattillo S; Rosendaal FR; Peyvandi F
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33096882
[TBL] [Abstract][Full Text] [Related]
18. Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.
Buetler VA; Agbariah N; Schild DP; Liechti FD; Wieland A; Andina N; Hammann F; Kremer Hovinga JA
Front Med (Lausanne); 2022; 9():890661. PubMed ID: 35655852
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura.
Lu R; Sui J; Zheng XL
Blood Adv; 2020 Nov; 4(21):5378-5388. PubMed ID: 33141886
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point].
Poullin P
Transfus Clin Biol; 2021 Nov; 28(4):380-385. PubMed ID: 34464709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
